Back to results
US 7,070,804 B2Granted
Chewable tablet containing lysine
AssigneeBoehringer Ingelheim International GmbH
InventorsValter Gianesello, Claudia Cappellini, Michael David Marocchi
Life of this patent
Estimating the term…
Abstract
A tablet with enhanced compliance by humans, in particular children and/or juveniles, comprising: (a) a vitamin; (b) lysine or a pharmaceutically acceptable salt thereof; (c) a sweetener; and (d) a pharmaceutically or dietetically acceptable carrier.
Claims11
A tablet comprising:
- (a) at least one vitamin;
- (b) at least one mineral selected from the group consisting of:
- manganese (II) gluconate, copper (II) carbonate, calcium phosphate, ferrous (II) fumarate, zinc oxide, and magnesium oxide,
- (c) lysine or a pharmaceutically acceptable salt thereof;
- (d) at least one sweetener, and
- (e) a pharmaceutically or dietetically acceptable carrier,
- wherein said tablet is obtainable by mixing of the different components (a) to (e) and
- wherein said tablet is formed by direct compression, and
- wherein the vitamin is a mixture of vitamins consisting essentially of:
- 0.4 mg to 0.8 mg of β-carotene, 500 IU to 1500 IU of vitamin A palmitate, 0.3 mg to 1.0 mg of vitamin B1 nitrate, 0.3 mg to 1.0 mg of vitamin B2, 0.3 mg to 1.0 mg of vitamin B6 hydrochloride, 0.4 μg to 1.0 μg of vitamin B12, 15 mg to 40 mg of vitamin C, 100 IU to 300 IU of vitamin D3, 3.0 mg to 9.5 mg of vitamin E acetate, 20 μg to 80 μg of folic acid, 10 μg to 25 μg of vitamin H, and 4 mg to 10 mg of vitamin PP, all per unit dosage.
7 more elements
A chewable tablet comprising
- (a) at least one vitamin;
- wherein the vitamin is selected from the group consisting of β-carotene, vitamin A palmitate, vitamin B, nitrate, vitamin B2, vitamin B6 hydrochloride, vitamin B12, vitamin C, vitamin D3, vitamin E acetate, folic acid, vitamin H and vitamin PP,
- (b) at least one mineral wherein the mineral is a mixture of minerals consisting essentially of:
- 0.2 mg to 0.8 mg of copper (II) carbonate, 150 mg to 300 mg of dicalcium phosphate anhydrous, 8.0 mg to 20 mg of ferrous (II furnarate, 4 mg to 9 mg of zinc oxide, and 12 mg to 28 mg of magnesium oxide:
- (c) lysine or a pharmaceutically acceptable salt thereof;
- (d) at least one sweetener;
- and
- (e) a pharmaceutically or dietetically acceptable carrier,
- (f) wherein said tablet is obtainable by mixing the different components (a) to
- (e) and wherein said tablet is formed by direct compression.
7 more elements
A chewable tablet comprising:
- (a) a mixture of vitamins consisting essentially of:
- 0.4 mg to 0.8 mg of β-carotene, 500 IU to 1500 IU of vitamin A palmitate, 0.3 mg to 1.0 mg of vitamin B1 nitrate, 0.3 mg to 1.0 mg of vitamin B2, 0.3 mg to 1.0 mg of vitamin B6 hydrochloride, 0.4 μg to 1.0 μg of vitamin B12, 15 mg to 40 mg of vitamin C, 100 IU to 300 IU of vitamin D3, 3.0 mg to 9.5 mg of vitamin E acetate, 20 μg to 80 μg of folic acid, 10 μg to 25 μg of vitamin H, and 4 mg to 10 mg of vitamin PP.
- (b) a mixture of minerals consisting essentially of 0.2 mg to 0.8 mg of copper (II) carbonate, 150 mg to 300 mg of dicalcium phosphate anhydrous, 8.0 mg to 20 mg of ferrous (II) furnarate, 4 mg to 9 mg of zinc oxide and 12 mg to 28 mg of magnesium oxide,
- (c) 10 mg to 100 mg of (L)-lysine monohydrochloride per unit dosage,
- (d) a mixture of sweeteners and flavoring agents comprising:
- 1.0 mg to 10.0 mg of aspartame, 5.0 mg to 50.0 mg of glucose syrup, 200 mg to 800 mg of sorbitol, and 5.0 mg to 50.0 mg of natural orange flavor;
- (e) a pharmaceutically or dietetically acceptable carrier,
- wherein the tablet weighs 500 mg to 2000 mg.
5 more elements
Dependencies are inferred from the claim text.